GPR35 and metabolic disease: An alternative way is to relate GPR35 phenotypes to the markers for endothelial (dys)function, such as flow-mediated endothelium-dependent vasodilation or the circulating endothelial microparticles in the human population.53,54 This will provide the prognostic value of GPR35 in the setting of cardiovascular and metabolic disorders.